Rheumatology
Comprehensive Rheumatology for Joint, Autoimmune & Connective-Tissue Health.
Early diagnosis, targeted biologics, and multidisciplinary care for pain-free movement and systemic well-being.
The Rheumatology Service at Burjeel Medical City offers an integrated approach to treating inflammatory arthritis, connective-tissue diseases, vasculitis, crystalline arthropathies, metabolic bone disorders, and pediatric rheumatic diseases. Our multidisciplinary care teams work with specialists in orthopedics, nephrology, pulmonology, dermatology, ophthalmology, and rehabilitation to ensure complete management of systemic effects and functional limitations.
Board-certified
adult and pediatric rheumatologists6,500+
outpatient visits and 1,200 infusion sessions in 202489%
remission/low-disease activity in RA at 6 months (DAS-28 score)On-site
musculoskeletal ultrasound and capillaroscopy for real-time diagnosisCommon Conditions & Subspecialty Clinics.
- Pre-conception planning for women with autoimmune disease
- High-risk pregnancy care for lupus, antiphospholipid syndrome (APS), and other connective tissue diseases (CTDs)
- Early detection of synovitis in inflammatory arthritis
- Ultrasound-guided joint aspiration and steroid injection
- Juvenile idiopathic arthritis (JIA)
- Juvenile dermatomyositis
- Autoinflammatory syndromes (e.g., periodic fever syndromes)
- Primary and secondary osteoporosis
- Paget disease of bone
- Chronic kidney disease–mineral bone disorder (CKD-MBD)
- Gout
- Calcium pyrophosphate deposition disease (CPPD/pseudogout)
- Basic calcium phosphate crystal disease (BCP)
- Giant-cell arteritis (temporal arteritis)
- ANCA-associated vasculitis (granulomatosis with polyangiitis [GPA], microscopic polyangiitis [MPA])
- Behçet disease
- Polyarteritis nodosa
- Systemic lupus erythematosus (SLE)
- Systemic sclerosis (scleroderma)
- Sjögren syndrome
- Mixed connective-tissue disease (MCTD)
- Rheumatoid arthritis (RA)
- Psoriatic arthritis
- Ankylosing spondylitis
- Axial spondyloarthritis
- Reactive arthritis
Procedures & Treatments.
Osteoporosis agents (bisphosphonates, denosumab, teriparatide, romosozumab)
Urate-lowering therapy (allopurinol, febuxostat, pegloticase)
IVIG & Cyclophosphamide for refractory systemic autoimmune diseases
Targeted Synthetic DMARDs (JAK inhibitors, PDE4 inhibitor)
Biologic DMARDs (TNF-alpha inhibitors, IL-6 blockers, IL-17/IL-23 inhibitors, CTLA-4-Ig, anti-CD20 monoclonal antibodies)
Conventional DMARDs (methotrexate, leflunomide, sulfasalazine, hydroxychloroquine)
Bone-density testing via DXA with FRAX fracture-risk analysis
Comprehensive autoimmune serology (ANA profile, ENA, ANCA, anti-CCP, HLA-B27)
Dual-energy CT for crystal discrimination (urate vs. CPPD)
Nailfold capillaroscopy for systemic sclerosis and dermatomyositis
High-resolution musculoskeletal ultrasound for synovitis, enthesitis, gout tophus detection
Dietitian-led gout-friendly and anti-inflammatory meal planning
Dermatology co-management for psoriatic skin manifestations
Ophthalmology screening for hydroxychloroquine retinopathy
Physical and occupational therapy for joint protection and strength
Autologous blood injections for chronic tendinopathy (with Sports Medicine)
Prolia® and Reclast® infusions/injections for osteoporosis
Infusion suite for rituximab, tocilizumab, and belimumab with protocol-driven monitoring
Large-joint arthrocentesis and crystal analysis
Ultrasound-guided joint and tendon sheath injections (corticosteroid, hyaluronic acid, PRP)
Care Pathway & Coordination.
Rapid Access Clinic
New inflammatory arthritis seen within 2 weeks; baseline labs and ultrasound performed on the same day.
Treat-to-Target Plan
DAS-28 or ASDAS metrics set; DMARD therapy initiated with steroid bridging if necessary.
Infusion & Injection Services
Biologic or targeted therapy started within 2-4 weeks if inadequate response.
Monitoring & Adjustment
Disease-activity score, labs every 8–12 weeks; therapy tapered upon sustained remission.
Comorbidity Management
Cardiovascular risk, vaccination, bone health addressed in yearly reviews.
Flare Access & Virtual Visits
Same-day tele-rheum or urgent slot for disease flares; remote PROM collection.
Technology & Facilities.
Point-of-Care Musculoskeletal Ultrasound (12 MHz)
On-table dynamic assessment and guided injection
Infusion Center with Biologic-Tracking EMR Module
Real-time adverse-event monitoring Dual-Energy CT Scanner
